Intestinal levodopa infusion in PD - the first randomized trial

Nature Reviews Neurology

Volumn 10, Issue 3, 2014, Pages 128-129

  Katzenschlager, Regina ^a   Poewe, Werner ^b  

^a DANUBE HOSPITAL   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; PLACEBO; CARBIDOPA;

ARTICLE; DIGESTIVE TUBE; DRUG DOSE REGIMEN; GASTROJEJUNOSTOMY; GUILLAIN BARRE SYNDROME; HUMAN; INFECTION; INTRAJEJUNAL DRUG ADMINISTRATION; MALABSORPTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PERITONITIS; POLYNEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; TREATMENT DURATION; FEMALE; MALE; NOTE;

CARBIDOPA; FEMALE; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE;

EID: 84895926746     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.26     Document Type: Article

References (10)

1. Olanow, C. W. et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: A randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13 141-149 (2014
2. Olanow, C. W., Obeso, J. A. & Stocchi, F. Continuous dopamine-receptor treatment of Parkinson's disease: Scientific rationale and clinical implications. Lancet Neurol. 5, 677-687 (2006
3. Nutt, J. G. Pharmacokinetics and pharmacodynamics of levodopa. Mov. Disord. 23 (Suppl. 3), S580-S584 (2008
4. Fox, S. H. et al. The Movement Disorder Society evidence-based medicine review update: Treatments for the motor symptoms of Parkinson's disease. Mov. Disord. 26 (Suppl. 3), S2-S41 (2011
5. Deuschl, G. & Agid, Y. Subthalamic neurostimulation for Parkinson's disease with early fluctuations: Balancing the risks and benefits. Lancet Neurol. 12, 1025-1034 (2013
6. Wirth, R. et al. Complications and mortality after percutaneous endoscopic gastrostomy in geriatrics: A prospective multicenter observational trial. J. Am. Med. Dir. Assoc. 13, 228-233 (2012
7. Richter-Schrag, H. J. et al. Risk factors and complications following percutaneous endoscopic gastrostomy: A case series of 1041 patients. Can. J. Gastroenterol. 25, 201-206 (2011
8. Toth, C. et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann. Neurol. 69, 28-36 (2010
9. Fernandez, H. H. et al. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results. Parkinsonism Relat. Disord. 19, 339-345 (2013
10. Müller, T. et al. Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery. Parkinsonism Relat. Disord. 19, 501-507 (2013